Login to Your Account

Spy added CBRNE possibilities after action on GSK, Sanofi

By Randy Osborne
Staff Writer

Thursday, July 20, 2017

As the company made its second acquisition in a month, Emergent Biosolutions Inc. CEO Daniel Abdun-Nabi vowed that the hunt for more prospects will continue and could include "vaccines, therapeutics, devices across the chemical, biological, radiological, nuclear and explosives."

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription